$OMEX
ODYSSEY MARINE EXPLORATION INC

2022 Q3 Form 10-Q Financial Statement

#000095017022017388 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $358.4K $390.3K $250.2K
YoY Change 81.89% 114.05% -16.97%
Cost Of Revenue
YoY Change
Gross Profit $358.4K $390.3K $250.2K
YoY Change 81.89% 114.05% -16.97%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $2.214M $2.292M $4.286M
YoY Change -34.28% 34.84% 215.16%
% of Gross Profit 617.59% 587.29% 1713.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.18K $7.960K $2.250K
YoY Change 786.83% 76.11%
% of Gross Profit 5.07% 2.04% 0.9%
Operating Expenses $2.214M $2.292M $4.286M
YoY Change -34.28% 34.84% 215.16%
Operating Profit -$3.720M -$3.131M -$4.036M
YoY Change 17.31% -36.7% 281.22%
Interest Expense $3.665M $3.550M -$2.949M
YoY Change -227.83% 35.03% 33.43%
% of Operating Profit
Other Income/Expense, Net -$3.670M -$3.410M $208.7K
YoY Change 16474.38% -386.33% -360.81%
Pretax Income -$7.390M -$6.541M -$1.563M
YoY Change 29.97% 74.17% -53.34%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.455M -$4.683M $76.62K
YoY Change 33.53% 110.26% -103.24%
Net Earnings / Revenue -1522.07% -1200.04% 30.63%
Basic Earnings Per Share -$0.28 -$0.30 $0.02
Diluted Earnings Per Share -$0.28 -$0.30 $5.369K
COMMON SHARES
Basic Shares Outstanding 19.49M 15.80M
Diluted Shares Outstanding 19.48M 15.80M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.783M $10.53M $2.275M
YoY Change 91.43% 120.1% -63.07%
Cash & Equivalents $6.800M $10.50M $2.275M
Short-Term Investments
Other Short-Term Assets $481.4K $547.1K $776.6K
YoY Change 123.93% 67.94% 32.22%
Inventory
Prepaid Expenses $732.6K
Receivables $422.7K $329.5K $268.9K
Other Receivables $10.00 $1.300K $0.00
Total Short-Term Assets $7.687M $11.41M $3.320M
YoY Change 91.65% 112.51% -51.96%
LONG-TERM ASSETS
Property, Plant & Equipment $648.2K $702.7K $479.1K
YoY Change 25.56% 27.08% -22.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.147M $3.849M $3.254M
YoY Change 37.96% 37.0% 37.3%
Other Assets $34.30K $34.30K $34.30K
YoY Change -17.97% -17.97% -17.97%
Total Long-Term Assets $6.613M $6.389M $5.589M
YoY Change 22.81% 22.26% 15.26%
TOTAL ASSETS
Total Short-Term Assets $7.687M $11.41M $3.320M
Total Long-Term Assets $6.613M $6.389M $5.589M
Total Assets $14.30M $17.80M $8.909M
YoY Change 52.2% 68.0% -24.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.569M $2.734M $1.817M
YoY Change -6.69% -0.33% 24.17%
Accrued Expenses $37.89M $34.15M $28.01M
YoY Change 28.17% 24.55% 47.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $20.28M $20.38M $22.78M
YoY Change -29.71% -31.87% -25.59%
Total Short-Term Liabilities $60.74M $57.27M $52.61M
YoY Change -0.7% -4.68% -2.37%
LONG-TERM LIABILITIES
Long-Term Debt $24.35M $24.17M $18.47M
YoY Change 53.99% 72.51% 60.77%
Other Long-Term Liabilities $186.4K $225.9K $315.8K
YoY Change -48.09% -43.59% -92.66%
Total Long-Term Liabilities $24.54M $24.40M $18.79M
YoY Change 51.73% 69.29% 19.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.74M $57.27M $52.61M
Total Long-Term Liabilities $24.54M $24.40M $18.79M
Total Liabilities $85.28M $81.67M $71.40M
YoY Change 100.52% 97.83% 2.48%
SHAREHOLDERS EQUITY
Retained Earnings -$293.5M -$288.0M -$275.1M
YoY Change 3.76%
Common Stock $264.6M $264.3M $249.1M
YoY Change 4.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$28.84M -$23.68M -$26.03M
YoY Change
Total Liabilities & Shareholders Equity $14.34M $17.82M $8.909M
YoY Change 52.59% 68.17% -24.24%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$5.455M -$4.683M $76.62K
YoY Change 33.53% 110.26% -103.24%
Depreciation, Depletion And Amortization $18.18K $7.960K $2.250K
YoY Change 786.83% 76.11%
Cash From Operating Activities -$3.360M -$986.9K -$1.167M
YoY Change 158.79% -29.93% -69.05%
INVESTING ACTIVITIES
Capital Expenditures -$4.420K -$309.5K -$3.000K
YoY Change 100.0% 2121.97%
Acquisitions
YoY Change
Other Investing Activities $0.00 $342.1K
YoY Change
Cash From Investing Activities -$4.420K -$309.5K $339.1K
YoY Change 100.0% 2121.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -388.2K 9.725M -440.5K
YoY Change -779.71% 897.01% -153.72%
NET CHANGE
Cash From Operating Activities -3.360M -986.9K -1.167M
Cash From Investing Activities -4.420K -309.5K 339.1K
Cash From Financing Activities -388.2K 9.725M -440.5K
Net Change In Cash -3.752M 8.429M -1.268M
YoY Change 201.79% -1986.21% -57.01%
FREE CASH FLOW
Cash From Operating Activities -$3.360M -$986.9K -$1.167M
Capital Expenditures -$4.420K -$309.5K -$3.000K
Free Cash Flow -$3.355M -$677.3K -$1.164M
YoY Change 158.89% -51.42% -69.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000798528
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5632602
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5602915
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31895
dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
22784010
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2991422
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1018684
dei Entity Address Address Line1
EntityAddressAddressLine1
205 S. Hoover Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33609
dei City Area Code
CityAreaCode
813
dei Local Phone Number
LocalPhoneNumber
876-1776
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
OMEX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19486906
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10534828
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2274751
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
329540
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
268867
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
547077
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
776630
CY2022Q2 us-gaap Assets Current
AssetsCurrent
11411445
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3320248
CY2022Q2 omex Property Plant And Equipment Subject To Operating Leases
PropertyPlantAndEquipmentSubjectToOperatingLeases
382587
CY2021Q4 omex Property Plant And Equipment Subject To Operating Leases
PropertyPlantAndEquipmentSubjectToOperatingLeases
461109
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5312495
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5584881
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
702694
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
479143
CY2022Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3848925
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3253950
CY2022Q2 omex Exploration License
ExplorationLicense
1821251
CY2021Q4 omex Exploration License
ExplorationLicense
1821251
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34295
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34295
CY2022Q2 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
5704471
CY2021Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
5109496
CY2022Q2 us-gaap Assets
Assets
17818610
CY2021Q4 us-gaap Assets
Assets
8908887
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2734296
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1817445
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
33978084
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27844107
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174588
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
163171
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
20384010
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
57270978
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52608733
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
24174983
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
18472997
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
225944
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
315795
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
24400927
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
18788792
CY2022Q2 us-gaap Liabilities
Liabilities
81671905
CY2021Q4 us-gaap Liabilities
Liabilities
71397525
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19464950
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19464950
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14309315
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14309315
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1946
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1431
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
264323108
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
249055600
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-288004571
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-275090857
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-23679517
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-26033826
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-40173778
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-36454812
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63853295
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-62488638
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17818610
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8908887
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
390278
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
182334
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
689884
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
474010
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2292082
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1699809
CY2022Q2 us-gaap Assets
Assets
17800000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4210578
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2022Q2 omex Operations And Research Expense
OperationsAndResearchExpense
1229634
CY2021Q2 omex Operations And Research Expense
OperationsAndResearchExpense
3429165
omex Operations And Research Expense
OperationsAndResearchExpense
6286169
omex Operations And Research Expense
OperationsAndResearchExpense
5226602
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3521716
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
5128974
us-gaap Costs And Expenses
CostsAndExpenses
10496747
us-gaap Costs And Expenses
CostsAndExpenses
8218024
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3131438
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4946640
us-gaap Operating Income Loss
OperatingIncomeLoss
-9806863
us-gaap Operating Income Loss
OperatingIncomeLoss
-7744014
CY2022Q2 us-gaap Interest Expense
InterestExpense
3550361
CY2021Q2 us-gaap Interest Expense
InterestExpense
2629253
us-gaap Interest Expense
InterestExpense
6775921
us-gaap Interest Expense
InterestExpense
5009729
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
140361
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3820199
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49896
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3874583
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3410000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1190946
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6825817
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1135146
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6541438
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3755694
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16632680
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8879160
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-6541438
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-3755694
us-gaap Profit Loss
ProfitLoss
-16632680
us-gaap Profit Loss
ProfitLoss
-8879160
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1857953
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1528195
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3718966
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2931443
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4683485
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2227499
us-gaap Net Income Loss
NetIncomeLoss
-12913714
us-gaap Net Income Loss
NetIncomeLoss
-5947717
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
625293
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
1448697
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
713879
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15803746
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13023330
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15088662
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12818266
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15803746
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13023330
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15088662
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12818266
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-72445582
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
412198
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9274562
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5446965
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-6541438
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63853295
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-60490475
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
343605
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-3755694
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63902564
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-62488638
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
546496
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9274562
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5446965
us-gaap Profit Loss
ProfitLoss
-16632680
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63853295
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57911273
us-gaap Profit Loss
ProfitLoss
-8879160
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-63902564
us-gaap Profit Loss
ProfitLoss
-16632680
us-gaap Profit Loss
ProfitLoss
-8879160
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
594975
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
438656
us-gaap Depreciation
Depreciation
10325
us-gaap Depreciation
Depreciation
4517
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
73448
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
60545
omex Amortization Of Loan Prepayment Premium
AmortizationOfLoanPrepaymentPremium
300000
omex Amortization Of Loan Prepayment Premium
AmortizationOfLoanPrepaymentPremium
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
140153
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-74268
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
78522
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
71207
us-gaap Share Based Compensation
ShareBasedCompensation
731498
us-gaap Share Based Compensation
ShareBasedCompensation
625293
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3818750
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1475407
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8260077
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1112293
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60672
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
97464
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-229553
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-261636
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6336234
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2550544
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6716044
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6896227
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2672550
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2838329
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
312399
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13930
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-312399
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13930
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2200000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1184295
omex Payment Of Operating Lease Liability
PaymentOfOperatingLeaseLiability
78434
omex Payment Of Operating Lease Liability
PaymentOfOperatingLeaseLiability
68185
omex Proceeds From Sale Of Equity Of Subsidiary
ProceedsFromSaleOfEquityOfSubsidiary
713879
us-gaap Repayments Of Debt
RepaymentsOfDebt
5073804
us-gaap Repayments Of Debt
RepaymentsOfDebt
354582
omex Repurchase Of Stockbased Awards Withheld For Payment Of Withholding Tax Requirements
RepurchaseOfStockbasedAwardsWithheldForPaymentOfWithholdingTaxRequirements
524263
omex Repurchase Of Stockbased Awards Withheld For Payment Of Withholding Tax Requirements
RepurchaseOfStockbasedAwardsWithheldForPaymentOfWithholdingTaxRequirements
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1790848
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16512375
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11245026
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1376852
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2274751
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6163205
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10534828
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4786353
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Stock Issued1
StockIssued1
339262
us-gaap Stock Issued1
StockIssued1
100000
omex Common Stock Accrued Interest Write Off
CommonStockAccruedInterestWriteOff
0
omex Common Stock Accrued Interest Write Off
CommonStockAccruedInterestWriteOff
34520
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
916158
us-gaap Operating Lease Cost
OperatingLeaseCost
82000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1112293
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
916158
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Management uses estimates and assumptions in preparing these condensed consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 omex Exploration License Impairments
ExplorationLicenseImpairments
0
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the 2021 condensed consolidated financial statements in order to conform to the classifications used in 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The reclassifications had no impact to operations or working capital.</span></p>
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4683485
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2227499
us-gaap Net Income Loss
NetIncomeLoss
-12913714
omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
P3M
CY2021Q2 omex Exploration License Impairments
ExplorationLicenseImpairments
0
omex Exploration License Impairments
ExplorationLicenseImpairments
0
omex Exploration License Impairments
ExplorationLicenseImpairments
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15088662
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12818266
CY2022Q2 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
4.85
CY2021Q2 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
6.55
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
5.38
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
6.91
us-gaap Net Income Loss
NetIncomeLoss
-5947717
CY2022Q2 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-4683485
CY2021Q2 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-2227499
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12913714
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5947717
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15803746
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13023330
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15088662
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12818266
CY2022Q2 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
15803746
CY2021Q2 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
13023330
omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
15088662
omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
12818266
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022Q2 us-gaap Loans Payable
LoansPayable
44558993
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
329540
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
268867
CY2022Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4939515
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4939515
CY2022Q2 omex Offering Fees Withheld To Cover Offering Costs
OfferingFeesWithheldToCoverOfferingCosts
1800000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500000
CY2022Q2 omex Working Capital Deficit
WorkingCapitalDeficit
45900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
625293
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
76920
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
156524
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
92884
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
326328
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
54500
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
41000
us-gaap Operating Lease Cost
OperatingLeaseCost
109000
CY2021Q4 us-gaap Loans Payable
LoansPayable
41257007
us-gaap Debt Conversion Description
DebtConversionDescription
Anytime from 30 days after the maturity date, 37N had the option to convert all or a portion of the outstanding amount of the indebtedness into conversion shares equal to the quotient obtained by dividing (A) 125% of the amount of the indebtedness, by (B) the lower of $5.94 and 70% of the 10-day VWAP.
omex Percentage Of Shares Outstanding Post Conversion
PercentageOfSharesOutstandingPostConversion
0.199
omex Percentage Of Outstanding Voting Securities
PercentageOfOutstandingVotingSecurities
0.199
omex Percentage Of Payment Of Unpaid Principal Amount
PercentageOfPaymentOfUnpaidPrincipalAmount
1.10
omex Prepayment Notice Prior To Repayment Period
PrepaymentNoticePriorToRepaymentPeriod
P10D
omex Exercise Notice Period
ExerciseNoticePeriod
P10D
omex Percentage Of Number Of Shares Issued After Exercise Notice
PercentageOfNumberOfSharesIssuedAfterExerciseNotice
0.199
omex Percentage Of Payment Of Unpaid Principal Amount After Exercise Notice
PercentageOfPaymentOfUnpaidPrincipalAmountAfterExerciseNotice
1.30
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2200000
omex Percentage Of Face Value Of Note
PercentageOfFaceValueOfNote
1.10
CY2022Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
100000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
300000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
418852
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
343605
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
731498
CY2022Q2 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2021Q2 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2022Q2 us-gaap Loans Receivable With Variable Rates Of Interest1
LoansReceivableWithVariableRatesOfInterest1
0

Files In Submission

Name View Source Status
0000950170-22-017388-index-headers.html Edgar Link pending
0000950170-22-017388-index.html Edgar Link pending
0000950170-22-017388.txt Edgar Link pending
0000950170-22-017388-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img259109917_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
omex-20220630.htm Edgar Link pending
omex-20220630.xsd Edgar Link pending
omex-ex31_1.htm Edgar Link pending
omex-ex31_2.htm Edgar Link pending
omex-ex32_1.htm Edgar Link pending
omex-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
omex-20220630_cal.xml Edgar Link unprocessable
omex-20220630_def.xml Edgar Link unprocessable
omex-20220630_lab.xml Edgar Link unprocessable
omex-20220630_pre.xml Edgar Link unprocessable
omex-20220630_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending